SECreport

Form SCHEDULE 13D PALVELLA THERAPEUTICS, Filed by: Kaupinen Wes

Pieris Pharmaceuticals, Inc.  (PIRS) 
NASDAQ:AMEX Investor Relations: ir.pieris.com